Table 2.
No. | T stage | Size, mm | N stage | Histology | Age | ER status | PR status | HER2 status | RQ CK8 | RQ CK18 | RQ CKl9 |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | pT1b | 11 | pN1a (1/2) | inv. duct | 58 | neg. | neg. | n.d. | 7.47l | 3.272 | 102.127 |
2 | cT2 | 27 | n.d. | inv. duct | 39 | n.d. | n.d. | n.d. | 3.349 | 1.528 | 32.533 |
3 | pT1c | l9 | pN0 (0/1) | inv. duct | 52 | neg. | neg. | pos. | 0.90l | 0.32 | 28.47 |
4 | pT1c | 12 | pN1a (1/14) | inv. duct | 73 | pos. | pos. | neg. | 3.126 | 2.639 | 185.744 |
5 | pT1b | 6 | pN0 (0/3) | inv. duct | 66 | pos. | pos. | pos. | 0.306 | 0.185 | 14 |
6 | pT1c | 12 | pN0 (0/2) | inv. duct | 66 | pos. | pos. | neg. | 203.192 | 117.464 | 3338.293 |
7 | pT2 | 25 | pN0 (0/1) | inv. duct | 70 | pos. | pos. | pos. | 63.171 | 46.598 | 1269.884 |
8 | pT1c | 13 | pN0 (0/2) | inv. duct | 70 | pos. | pos. | pos. | n.d. | n.d. | n.d. |
9 | pT2 | 30 | pN0 (0/3) | inv. duct | 46 | pos. | pos. | pos. | 1.432 | 0.806 | 21.22 |
10 | pT2 | 22 | pN0 (0/l) | inv. duct | 48 | pos. | pos. | neg. | 5.576 | 3.424 | 103.026 |
11 | pT1c | 18 | pN0 (0/2) | inv. duct | 63 | pos. | pos. | neg. | 0.075 | 0.054 | 1.873 |
12 | cT3 | 55 | pN0 (0/2) | inv. duct | 53 | neg. | neg. | neg. | 0.105 | 0.121 | 1.259 |
13 | pT1c | 12 | pN0 (0/2) | inv. duct | 52 | pos. | pos. | pos. | 1.89 | 1.019 | 72.961 |
14 | pT2 | 25 | pN0 (0/7) | inv. lob | 63 | pos. | pos. | pos. | 1.629 | 1.786 | 52.762 |
15 | pT1c | 13 | pN0 (0/1) | inv. duct | 70 | pos. | pos. | pos. | 0.407 | 0.634 | 17.851 |
16 | pT2 | 40 | pN0 (0/5) | inv. duct | 70 | pos. | pos. | pos. | 155.595 | 135.514 | 4635.474 |
17 | pT1c | 20 | pN0 (0/1) | inv. duct | 71 | neg. | neg. | neg. | 6.834 | 4.656 | 106.96 |
18 | pT1c | 15 | pN0 (0/1) | inv. duct | 51 | pos. | pos. | neg. | 402.414 | 173.955 | 6310.456 |
19 | pT1c | 18 | pN0 (0/4) | inv. duct | 50 | pos. | neg. | pos. | 2.911 | 2.64 | 41.437 |
20 | pT1c/pT1b | l2/9 | pN0 (0/1) | inv. duct | 70 | pos./pos. | pos./pos. | pos./neg. | 273.943 | 142.751 | 1769.476 |
No correlation between tumor data and RQ values could be shown. For patients 3, 5, 11, 12, and 15, a downward deviation of the RQ values from the average RQ value is seen; in patients 6, 7, 16, 18, and 20, the RQ values deviate upwards from the average RQ.
ER = Estrogen receptor, PR = progesterone receptor, HER2 = human epidermal growth factor receptor, RQ = relative expression, CK = cytokeratin, n.d. = not detectable, inv. duct = invasive ductal, inv. lob = invasive lobular, neg. = negative, pos. = positive.